Myriad Genetics Stock Forecast - Period Momentum Indicator

MYGN Stock  USD 22.62  0.08  0.35%   
Myriad Stock Forecast is based on your current time horizon. Although Myriad Genetics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Myriad Genetics' systematic risk associated with finding meaningful patterns of Myriad Genetics fundamentals over time.
  
At this time, Myriad Genetics' Payables Turnover is very stable compared to the past year. As of the 22nd of October 2024, Receivables Turnover is likely to grow to 9.82, while Inventory Turnover is likely to drop 5.47. . As of the 22nd of October 2024, Common Stock Shares Outstanding is likely to drop to about 75.2 M. In addition to that, Net Income Applicable To Common Shares is likely to drop to about 159.7 M.
Myriad Genetics has current Period Momentum Indicator of 0.08. Most investors in Myriad Genetics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Myriad Genetics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Myriad Genetics' price structures and extracts relationships that further increase the accuracy of the generated results. Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Myriad Genetics VolatilityBacktest Myriad GeneticsInformation Ratio  

Myriad Genetics Trading Date Momentum

On October 22 2024 Myriad Genetics was traded for  22.62  at the closing time. The top price for the day was 22.76  and the lowest listed price was  22.33 . The trading volume for the day was 369.5 K. The trading history from October 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.66% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Myriad Genetics to competition

Other Forecasting Options for Myriad Genetics

For every potential investor in Myriad, whether a beginner or expert, Myriad Genetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Myriad Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Myriad. Basic forecasting techniques help filter out the noise by identifying Myriad Genetics' price trends.

View Myriad Genetics Related Equities

 Risk & Return  Correlation

Myriad Genetics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Myriad Genetics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Myriad Genetics' current price.

Myriad Genetics Market Strength Events

Market strength indicators help investors to evaluate how Myriad Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Myriad Genetics shares will generate the highest return on investment. By undertsting and applying Myriad Genetics stock market strength indicators, traders can identify Myriad Genetics entry and exit signals to maximize returns.

Myriad Genetics Risk Indicators

The analysis of Myriad Genetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Myriad Genetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting myriad stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Myriad Genetics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myriad Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Myriad Stock

  0.62ERNA Eterna TherapeuticsPairCorr

Moving against Myriad Stock

  0.78WVE Wave Life Sciences TrendingPairCorr
  0.74GNFT GenfitPairCorr
  0.59GILD Gilead SciencesPairCorr
  0.56BMY Bristol Myers SquibbPairCorr
  0.53ZURA Zura Bio LimitedPairCorr
The ability to find closely correlated positions to Myriad Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myriad Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myriad Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myriad Genetics to buy it.
The correlation of Myriad Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myriad Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myriad Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myriad Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Myriad Genetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myriad Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myriad Genetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myriad Genetics Stock:
Check out Historical Fundamental Analysis of Myriad Genetics to cross-verify your projections.
To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.77)
Revenue Per Share
9.2
Quarterly Revenue Growth
0.153
Return On Assets
(0.06)
Return On Equity
(0.21)
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.